Skip to content
Search

Latest Stories

PDA now significantly involved in medicines related humanitarian projects

PDA now significantly involved in medicines related humanitarian projects
The PDA joined the International Pharmaceutical Federation (FIP) in 2022, gaining access to over 150 global pharmacy organizations and enabling it to promote its 'Medicines To' campaign at WHO meetings in Geneva

The Pharmacists’ Defence Association (PDA) has emerged as a key player in international humanitarian efforts, delivering millions of pounds worth of medical aid to disaster-hit regions.

This marks a significant evolution for the PDA, which has embraced a leadership role in global relief initiatives.


The PDA, a member of the Employed Pharmacists of Europe (EPhEU), responded to an urgent appeal from its Ukrainian members following the extensive damage to Ukraine's healthcare infrastructure during the military invasion.

As the elected Secretary General of EPhEU, PDA Chairman Mark Koziol orchestrated a campaign encouraging public donations through 'Medicines to Ukraine' posters displayed in pharmacies across Europe.

The campaign successfully raised over £4.5 million, which was used to procure and deliver essential medicines directly to Ukrainian Ministry of Health pharmacists.

Koziol's visit to Ukraine underscored the campaign's impact.

The initiative's efficiency was attributed to its pull system, responding to specific requests from the ground, in contrast to the traditional push model of sending surplus medicines.

This targeted approach ensured that the right medicines reached those in need.

Inspired by this success, the PDA sought to expand its humanitarian efforts globally.

In 2022, the PDA joined the International Pharmaceutical Federation (FIP), gaining access to a global network of over 150 pharmacy organisations.

This strategic move allowed the PDA to share its 'Medicines To' campaign ambitions at World Health Organisation (WHO) meetings in Geneva.

Koziol emphasised the importance of local knowledge and partnerships in implementing the 'Medicines To' model worldwide.

It is apparent that there are many parts of the world where this kind of support is needed right now, as well as understanding the need to anticipate what may happen in the future and how to be able to respond promptly.

"The ‘Medicines To’ model can be set up essentially anywhere, but it needs local network knowledge and partnership working ; it also needs a central co-ordinating facility,” said the PDA’s chair Mark Koziol.

“My ambition is that if we do well in building this scheme, then in 15 years’ time if there is a humanitarian crisis in any part of the world, the governments and the global relief organisations will all say – as far as delivering the medicines is concerned – then that’s a job for the pharmacists,” he continued

At the PDA's first FIP congress in Brisbane in 2023, the 'Medicines To' campaign received unanimous support from the FIP Council.

South African pharmacy leaders committed to launching the campaign in Africa, the region with the highest number of humanitarian crises per capita.

During the emotional signing ceremony, FIP Vice President Lars Ake Soderlund praised the PDA for accelerating FIP's humanitarian efforts since joining the federation.

The PDA's leadership in these humanitarian projects highlights the crucial role of pharmacists in global health crises and showcases the power of international collaboration in delivering essential medical aid.

More For You

NICE approves AstraZeneca’s twice-a-day tablet ‘capivasertib’ for advanced breast cancer

HR-positive, HER2-negative advanced breast cancer is currently incurable, and treatment aims to slow progression and prolong life

Gettyimages

NICE approves twice-a-day tablet for advanced breast cancer

Every year, thousands of people with hormone receptor (HR)-positive HER2-negative breast cancer could benefit from a new twice-a-day tablet, now set to be funded immediately through the Cancer Drugs Fund.

The National Institute for Health and Care Excellence (NICE) has approved the use of capivasertib (also known as Truqap), in combination with fulvestrant, as an option for around 1,100 adults with HR-positive HER2-negative breast cancer that has certain genetic mutations and has spread.

Keep ReadingShow less
ABPI and government fast-track VPAG scheme review to address high medicine payment rates

The 2025 VPAG payment rate for newer medicines has been set at 22.9 per cent.

Photo credit: gettyimages

Review of 2024 VPAG scheme to be completed by June

The Association of the British Pharmaceutical Industry (ABPI) and the government have agreed to bring forward a planned review of the 2024 Voluntary Scheme for Branded Medicines Pricing, Access, and Growth (VPAG), originally scheduled for autumn 2025.

The review is expected to be completed in June 2025, aligning with the anticipated release of the government’s 10-year NHS Plan and the Life Sciences Sector Plan as part of the broader industry strategy this summer.

Keep ReadingShow less
AAH upgrades ordering portal, making procurement easier for pharmacies

AAH Cascade compares prices and availability across suppliers

AAH Warehouse

AAH upgrades ordering portal to improve product visibility

Leading pharmaceutical wholesaler AAH Pharmaceuticals Ltd has introduced new digital functionalities to AAH Cascade, its independently managed ordering portal, making procurement easier and more cost-effective for pharmacies.

AAH Cascade compares product prices and availability across multiple suppliers, eliminating the need for manual searches.

Keep ReadingShow less
Majority of Brits neglect consistent skincare routine,  survey finds

On average, Brits go to bed without washing their face twice a week.

Photo credit: gettyimages

Skincare: One in five Brits go to bed without washing their face daily, survey finds

Nearly two-thirds of Brits (60 per cent) neglect a consistent skincare routine,with almost one in five going to bed without washing their face daily, according to a new survey by consumer health company Kenvue.

The UK-wide survey of 2,000 people revealed that one-third of respondents (34 per cent) spend five minutes or less on their daily skincare routine. On average, Brits go to bed without washing their face twice a week.

Keep ReadingShow less
Risk of pharmacy closures remains despite record funding uplift

Community pharmacy sector remains in a fragile position as the funding gap is still significant, says CCA.

gettyimages

Pharmacy closures still a risk as funding deal fails to cover costs – warns CCA

The community pharmacy sector has secured the largest funding uplift across the NHS, yet concerns remain that it may not be enough to prevent further closures and service reductions.

Following a six-week consultation with Community Pharmacy England (CPE), the government has approved a £3.073 billion funding package for 2025/26, supplemented by an additional £215 million to support Pharmacy First and other Primary Care Recovery Plan services.

Keep ReadingShow less